MA51969A1 - Steroids and their protein conjugates - Google Patents

Steroids and their protein conjugates

Info

Publication number
MA51969A1
MA51969A1 MA51969A MA51969A MA51969A1 MA 51969 A1 MA51969 A1 MA 51969A1 MA 51969 A MA51969 A MA 51969A MA 51969 A MA51969 A MA 51969A MA 51969 A1 MA51969 A1 MA 51969A1
Authority
MA
Morocco
Prior art keywords
steroids
protein conjugates
protein
conjugates
glucocorticoids
Prior art date
Application number
MA51969A
Other languages
French (fr)
Other versions
MA51969B2 (en
Inventor
Amy Han
William Olson
J Andrew Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2017/060434 external-priority patent/WO2018089373A2/en
Publication of MA51969A1 publication Critical patent/MA51969A1/en
Publication of MA51969B2 publication Critical patent/MA51969B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des conjugués de stéroïdes protéiques qui sont utiles, par exemple, pour l'administration spécifique à une cible de glucocorticoïdes (gc) à des cellules.Disclosed herein are protein steroid conjugates which are useful, for example, for the target-specific delivery of glucocorticoids (gc) to cells.

MA51969A 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES MA51969B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662419365P 2016-11-08 2016-11-08
PCT/US2017/060434 WO2018089373A2 (en) 2016-11-08 2017-11-07 Steroids and protein-conjugates thereof

Publications (2)

Publication Number Publication Date
MA51969A1 true MA51969A1 (en) 2022-08-31
MA51969B2 MA51969B2 (en) 2024-05-31

Family

ID=72291376

Family Applications (4)

Application Number Title Priority Date Filing Date
MA51971A MA51971B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES
MA51969A MA51969B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES
MA45752A MA45752B2 (en) 2016-11-08 2017-11-07 Steroids and their protein conjugates
MA51970A MA51970B1 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA51971A MA51971B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Family Applications After (2)

Application Number Title Priority Date Filing Date
MA45752A MA45752B2 (en) 2016-11-08 2017-11-07 Steroids and their protein conjugates
MA51970A MA51970B1 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Country Status (2)

Country Link
CL (1) CL2023000971A1 (en)
MA (4) MA51971B2 (en)

Also Published As

Publication number Publication date
MA51969B2 (en) 2024-05-31
MA45752B2 (en) 2022-12-30
CL2023000971A1 (en) 2023-09-29
MA51971A1 (en) 2022-06-30
MA45752A1 (en) 2020-06-30
MA51970B1 (en) 2023-11-30
MA51970A1 (en) 2022-08-31
MA51971B2 (en) 2024-05-31

Similar Documents

Publication Publication Date Title
MA50259A1 (en) Steroids and their antibody conjugates
MA45029B1 (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
MX2023014120A (en) Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods.
PH12020500240A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
MD3804737T2 (en) Compositions comprising bacterial strains
MA46708B1 (en) Anti-pd1 antibodies and their uses
MX2023011657A (en) Compositions comprising curons and uses thereof.
BR112018071612A2 (en) innovative bispecific polypeptides against cd137
MA41937B1 (en) DRUG CONJUGATES INCLUDING CLAUDINE ANTIBODIES 18.2
BR112018016450A2 (en) vcn enhancer compositions and methods of using them
MA40662B1 (en) Antibodies against tigit
MA40132A1 (en) Macrocyclic Inhibitors of Protein / protein Interactions pd-1 / pd-11 and cd80 (b7-1) / pd-li
CY1124704T1 (en) SOBETIROME PRODUCT
MX2019013693A (en) Bis-octahydrophenanthrene carboxamides and protein conjugates thereof.
MA46619B1 (en) Anti-il-33 antibodies and their uses
BR112021016056A2 (en) Claudin 6 antibodies and their uses
SA520412283B1 (en) Heavy Chain Antibodies Binding to CD22
BR112018009004A2 (en) anti-cd3-folate conjugates and their uses
MY191894A (en) Antibodies that bind zika virus envelope protein and uses thereof
MX2020011027A (en) Trivalent trispecific antibody constructs.
MX2020013389A (en) Terlipressin compositions and uses thereof.
MA45752B2 (en) Steroids and their protein conjugates
WO2019036725A3 (en) Tau aggregation peptide inhibitors
MX2021006941A (en) Anellosomes for delivering intracellular therapeutic modalities.
EA201900275A1 (en) STEROIDS AND THEIR PROTEIN CONJUGATES